Kiora Pharmaceuticals, Inc. (KPRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16M | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 41.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.93K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -41.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16M | -7.93K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | 100% | - | - | - |
| Gross Profit Growth % | - | - | - | - | -100% | 100% | - | - | - | 22.85% | - | - |
| Operating Expenses | 2.46M | 7.31M | 794.44K | 2.4M | 2.33M | 2.56M | 3.6M | 2.54M | 2.78M | 1.98M | 5.92M | 2.63M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | 17.36% | - | - | - |
| Selling, General & Admin | 1.61M | 1.46M | 1.44M | 1.35M | 1.49M | 1.33M | 1.38M | 1.54M | 1.3M | 872.62K | 1.42M | 1.1M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | 8.1% | - | - | - |
| Research & Development | 2.12M | 1.17M | 1.07M | 904.57K | 565.76K | 1.18M | 1.32M | 906.68K | 1.68M | 1.11M | 1.09M | 1.39M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | 10.53% | - | - | - |
| Other Operating Expenses | -1000K | 1000K | -1000K | 137.78K | 275.19K | 58.48K | 904.01K | 100.23K | -202.75K | 0 | 1000K | 143.62K |
| Operating Income | -2.5M | -7.31M | -794.44K | -2.4M | -2.33M | -2.56M | -3.6M | -2.54M | 13.22M | -1.99M | -5.92M | -2.63M |
| Operating Margin % | - | - | - | - | - | - | - | - | 82.64% | - | - | - |
| Operating Income Growth % | -7.4% | -185.03% | 77.95% | 5.84% | -117.62% | -28.74% | 39.14% | 3.35% | 789.85% | 25.01% | -59.83% | -9.62% |
| EBITDA | -2.46M | -7.3M | -783.88K | -2.39M | -2.33M | -2.56M | -3.6M | -2.54M | 13.23M | -1.98M | -5.91M | -2.61M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | 82.67% | - | - | - |
| EBITDA Growth % | -5.61% | -185.28% | 78.23% | 5.74% | -117.62% | -28.95% | 39.06% | 2.76% | 793.75% | 25.02% | -59.97% | -9.15% |
| D&A (Non-Cash Add-back) | 41.98K | 10.51K | 10.55K | 3.42K | 318 | 5.91K | 2.1K | 6.33K | 4.87K | 7.93K | 11.31K | 22.48K |
| EBIT | -2.5M | -5.27M | -2.52M | -2.26M | -2.06M | -2.41M | -2.7M | -2.42M | 13.21M | -2.18M | -2.5M | -2.49M |
| Net Interest Income | 139.34K | 190.31K | 201.82K | 225.24K | 276.63K | 417.41K | 248.84K | 342.1K | 223.05K | 45.52K | 49.91K | 45.09K |
| Interest Income | 139.34K | 190.31K | 201.82K | 225.24K | 276.63K | 438.86K | 248.84K | 342.1K | 223.05K | 45.52K | 49.91K | 45.09K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 21.45K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 84.78K | 143.59K | 178.11K | 131.68K | 260.38K | 406.19K | 188.91K | 323.24K | 231.11K | -186.09K | 155.63K | 19.2K |
| Pretax Income | -2.42M | -7.17M | -616.32K | -2.26M | -2.07M | -2.16M | -3.41M | -2.22M | 13.45M | -2.18M | -5.76M | -2.61M |
| Pretax Margin % | - | - | - | - | - | - | - | - | 84.08% | - | - | - |
| Income Tax | 0 | -649.97K | -643.13K | -112.06K | 123.01K | 2.07M | 0 | 0 | 0 | 90.32K | 0 | 0 |
| Effective Tax Rate % | 0% | 9.07% | 104.35% | 4.95% | -5.94% | -95.67% | 0% | 0% | 0% | -4.15% | 0% | 0% |
| Net Income | -2.42M | -6.52M | 26.81K | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M |
| Net Margin % | - | - | - | - | - | - | - | - | 84.08% | - | - | - |
| Net Income Growth % | -10.26% | -54.29% | 100.79% | 3.11% | -116.3% | -86.17% | 40.77% | 15% | 819.99% | 9.2% | -12.57% | -8.87% |
| Net Income (Continuing) | -2.42M | -6.52M | 26.81K | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.58 | -1.59 | 0.01 | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 3.46 | -0.29 | -0.81 | -0.79 |
| EPS Growth % | -11.54% | -12.77% | 100.77% | -1.89% | -115.03% | -386.21% | 0% | 32.91% | 388.33% | 80.92% | 89.48% | 89.25% |
| EPS (Basic) | -0.58 | -1.55 | 0.01 | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 4.67 | -0.29 | -0.81 | -0.79 |
| Diluted Shares Outstanding | 4.17M | 4.1M | 4.36M | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 35.03M | 7.71M | 7.11M | 3.29M |
| Basic Shares Outstanding | 4.17M | 4.17M | 4.29M | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 25.94M | 7.71M | 7.11M | 3.29M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |